| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |